Clinical Trial Update: Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating efficacy and safety in premenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Advanced Metastatic Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-02-26